Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-16 Purchase |
2022-12-19 07:09 am |
NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER |
30,000 | $1.1 | $33,000 | 46,337 (Direct) |
View |
| 2022-11-25 Purchase(A) |
2022-12-19 07:08 am |
NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER |
16,337 | $1.115 | $18,215 | 16,337 (Direct) |
View |
| 2022-11-25 Purchase |
2022-11-28 07:42 am |
NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH CHIEF FINANCIAL OFFICER |
16,337 | $1.115 | $18,215 | 16,377 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-17 6:52 pm |
PDS Biotechnology Corp | PDSB | VAN VOORHEES SETH Chief Financial Officer |
17,647 | $8.5 | $150,000 | 17,647 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-06-29 6:14 pm |
2023-06-13 2032-06-12 |
NRX Pharmaceuticals Inc. | NRXP | VAN VOORHEES SETH Chief Financial Officer |
0 | $0 | 325,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 4:06 pm |
N/A 2031-01-04 |
PDS Biotechnology Corp | PDSB | VAN VOORHEES SETH Chief Financial Officer |
202,800 | $0 | 202,800 (Direct) |
View |